about
Clinical translation of controlled protein delivery systems for tissue engineeringGene delivery to human adult and embryonic cell-derived stem cells using biodegradable nanoparticulate polymeric vectors.The effects of Runx2 immobilization on poly (epsilon-caprolactone) on osteoblast differentiation of bone marrow stromal cells in vitroGene therapy: design and prospects for craniofacial regeneration.Use of genetically modified muscle and fat grafts to repair defects in bone and cartilage.Osteoinduction and proliferation of bone-marrow stromal cells in three-dimensional poly (ε-caprolactone)/ hydroxyapatite/collagen scaffoldsEffects of the orientation of anti-BMP2 monoclonal antibody immobilized on scaffold in antibody-mediated osseous regenerationGene therapy: implications for craniofacial regeneration.BMP-2 gene modified canine bMSCs promote ectopic bone formation mediated by a nonviral PEI derivative.Co-encapsulation of anti-BMP2 monoclonal antibody and mesenchymal stem cells in alginate microspheres for bone tissue engineering.Osteogenic differentiation of mesenchymal stem cells promoted by overexpression of connective tissue growth factor.Functionalization of scaffolds with chimeric anti-BMP-2 monoclonal antibodies for osseous regeneration.Cyclic arginine-glycine-aspartate peptides enhance three-dimensional stem cell osteogenic differentiation.Stem cell- and scaffold-based tissue engineering approaches to osteochondral regenerative medicine.Collagen Sponge Functionalized with Chimeric Anti-BMP-2 Monoclonal Antibody Mediates Repair of Critical-Size Mandibular Continuity Defects in a Nonhuman Primate Model.BMP-2 gene activated muscle tissue fragments for osteochondral defect regeneration in the rabbit knee.Utilization of a genetically modified muscle flap for local BMP-2 production and its effects on bone healing: a histomorphometric and radiological study in a rat modelBone morphogenetic protein 2 gene transduction enhances the osteogenic potential of human urine-derived stem cells.Biomechanical analysis of engineered bone with anti-BMP2 antibody immobilized on different scaffolds.Alginate hydrogel as a promising scaffold for dental-derived stem cells: an in vitro study.Gene-activated tissue grafts for sustained bone morphogenetic protein-2 delivery and bone engineering: Is muscle with fascia superior to muscle and fat?Spinal fusion in the next generation: gene and cell therapy approaches.
P2860
Q28084738-DF681C67-6C56-4ABF-B62F-2FBCD7B82F0FQ33398327-4335B959-7F8A-4DC7-8B2C-AE1F86FC392EQ33697191-0B702951-28CA-45ED-B253-662819A799C0Q34007347-FE5F4AF6-2D49-4DEF-98C6-82FB5E74AF11Q35240986-94A53E57-695A-4A2B-9F1B-8B44E7BB06D7Q35600760-4EFDCA13-F2BC-4BFE-B950-05D4B05074D8Q35694061-7EB4EE8D-3816-4E6D-9637-4948A1F39541Q35764559-3488228C-10E4-44AE-8F6E-5FF78C4304C2Q36120376-2E06E7C0-E236-42D8-B141-51BBDA4E2B5FQ37026137-3885AA60-B5B9-4766-BA93-5277D0453E3FQ37177471-D177F6A7-9C0F-4112-8592-D14E6296002BQ37338417-3BAC1370-7435-426C-90F3-DE478730855FQ37414061-87522CCB-7B92-4189-A91C-B6F9D944AA9EQ37512645-D45B3EB7-7CD6-4237-B317-9D17A9F280BAQ37733510-7FDCBE4F-6EAB-4D92-B284-DEA7B3142111Q38660922-95A56247-4301-4971-AD8C-AE3FE0B921BBQ38880912-24814BDE-F05A-4605-AE9B-EF2DB68E0A97Q40180296-720CF1FF-0ACC-469F-A3C5-03A4477041FDQ40648322-D687EAF9-09C3-4184-A569-167176BE680FQ44682537-ACF6FCF2-3221-49F9-9CA4-2FD70F927F02Q45872335-80BCE5E5-C4C2-4BD4-A00A-10B6757C1FACQ51287412-23106481-D806-493C-88C5-70796A491226
P2860
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Bone tissue engineering and repair by gene therapy.
@en
type
label
Bone tissue engineering and repair by gene therapy.
@en
prefLabel
Bone tissue engineering and repair by gene therapy.
@en
P2093
P356
P1476
Bone tissue engineering and repair by gene therapy.
@en
P2093
Christopher H Evans
Mark S Vrahas
Mitchel B Harris
Oliver B Betz
Volker M Betz
P304
P356
10.2741/2724
P577
2008-01-01T00:00:00Z